Summary & Overview
HCPCS G9531: Ventricular Shunt, Brain Tumor, Multisystem Trauma or Antiplatelet Use
HCPCS Level II code G9531 documents patients with heightened hemorrhagic or procedural risk due to a ventricular shunt, brain tumor, multisystem trauma, or current use of specified antiplatelet medications. Nationally, this code identifies patients for whom procedural planning, monitoring, or alternative management strategies may be clinically relevant, and it supports accurate capture of clinical risk factors in administrative records. Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn how G9531 is used in clinical documentation workflows and typical sites of service, what clinical conditions and medications it covers, and where it fits in billing and administrative reporting. The publication also outlines benchmarks and common modifier usage where available, highlights implications for peri-procedural coding accuracy, and summarizes areas where input data was not provided. This summary is intended for a national audience of clinicians, coders, and policy analysts seeking concise guidance on the code’s clinical meaning and operational use.
Billing Code Overview
HCPCS Level II code G9531 indicates documentation that a patient has a ventricular shunt, brain tumor, multisystem trauma, or is currently taking an antiplatelet medication (including agents such as abciximab, anagrelide, cangrelor, cilostazol, clopidogrel, dipyridamole, eptifibatide, prasugrel, ticlopidine, ticagrelor, tirofiban, or vorapaxar).
Service Type: Pre-procedural or peri-procedural risk documentation / medication and device history
Typical Site of Service: Hospital inpatient or outpatient settings, emergency department, and procedural clinics where neurosurgical risk or antiplatelet exposure is relevant.
Clinical & Coding Specifications
Clinical Context
A patient arrives to the emergency department for evaluation of head trauma after a fall. The patient has a documented history of ventricular shunt placement for hydrocephalus and is currently taking clopidogrel. Neurosurgery is consulted to evaluate intracranial injury risk and need for imaging or operative intervention. The clinical workflow includes: triage and focused neurologic exam, review of medication list for antiplatelet agents (e.g., clopidogrel), verification of prior neurosurgical hardware (ventricular shunt) in the medical record or prior imaging, ordering of non-contrast head CT to assess for hemorrhage, consultation documentation noting the presence of a shunt and antiplatelet therapy, and disposition planning (observation, reversal strategies if indicated, or operative management). Typical site of service is the hospital emergency department, inpatient ward, or observation unit; neurosurgery clinic follow-up may occur for non-acute assessments. Service type: risk stratification and documentation of high-risk features for intracranial bleeding related to ventricular shunt, brain tumor, multisystem trauma, or active antiplatelet therapy as specified by G9531.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than typical for the service due to complexity (e.g., extensive coordination for multisystem trauma with shunt management). |